Cormark upgraded shares of STERIS’ (TSE:STE – Free Report) to a moderate buy rating in a research note released on Monday,Zacks.com reports.
Separately, Atb Cap Markets raised shares of STERIS’ to a “strong-buy” rating in a research note on Sunday, December 22nd.
View Our Latest Stock Report on STE
STERIS’ Price Performance
About STERIS’
STERIS’s MISSION IS TO HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science product and service solutions around the globe by providing innovative healthcare and life science product and service solutions around the globe.
Featured Articles
- Five stocks we like better than STERIS’
- Do ETFs Pay Dividends? What You Need to Know
- Moderna Shares Spike on H5N1 News—What’s Next for Investors?
- Dividend Capture Strategy: What You Need to Know
- Nebius Group (NBIS): A Small-Cap Backed by NVIDIA
- How to trade using analyst ratings
- Natural Gas Demand to Surge: Top 3 Stocks and ETFs to Consider
Receive News & Ratings for STERIS’ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS’ and related companies with MarketBeat.com's FREE daily email newsletter.
